APA (7th ed.) Citation

Jacobs, T. G., de Hoop-Sommen, M. A., Nieuwenstein, T., van der Heijden, J. E. M., de Wildt, S. N., Burger, D. M., . . . Freriksen, J. J. M. (2023). Lamivudine and Emtricitabine Dosing Proposal for Children with HIV and Chronic Kidney Disease, Supported by Physiologically Based Pharmacokinetic Modelling. Pharmaceutics, 15(5), 1424. https://doi.org/10.3390/pharmaceutics15051424

Chicago Style (17th ed.) Citation

Jacobs, Tom G., Marika A. de Hoop-Sommen, Thomas Nieuwenstein, Joyce E. M. van der Heijden, Saskia N. de Wildt, David M. Burger, Angela Colbers, and Jolien J. M. Freriksen. "Lamivudine and Emtricitabine Dosing Proposal for Children with HIV and Chronic Kidney Disease, Supported by Physiologically Based Pharmacokinetic Modelling." Pharmaceutics 15, no. 5 (2023): 1424. https://doi.org/10.3390/pharmaceutics15051424.

MLA (9th ed.) Citation

Jacobs, Tom G., et al. "Lamivudine and Emtricitabine Dosing Proposal for Children with HIV and Chronic Kidney Disease, Supported by Physiologically Based Pharmacokinetic Modelling." Pharmaceutics, vol. 15, no. 5, 2023, p. 1424, https://doi.org/10.3390/pharmaceutics15051424.